Highlights North China Pharmaceutical Company.Ltd

Equities

600812

CNE000000D16

End-of-day quote Shanghai S.E. Other stock markets 23:00:00 24/06/2024 BST			5-day change	1st Jan Change
4.16 ^CNY	+1.71%		-4.37%	-27.02%

06-03	China Grants Marketing Approval for Ampicillin Sodium as Active Pharmaceutical Ingredient	MT
05-24	North China Pharmaceutical's Unit Passes GMP Inspection	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

China Grants Marketing Approval for Ampicillin Sodium as Active Pharmaceutical Ingredient	06-03	MT
North China Pharmaceutical's Unit Passes GMP Inspection	05-24	MT
North China Pharmaceutical Company.Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	04-25	CI
North China Pharmaceutical Company.Ltd agreed to acquire the remaining 35.85% stake in NCPC Hebei Huamin Pharmaceutical Co., Ltd. from CCB Financial Asset Investment Co., Ltd. for CNY 670 million	03-29	CI
North China Pharmaceutical Company.Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	03-29	CI
North China Pharmaceutical Subsidiary Gets Europe's Compliance Certification for Drug Raw Material	02-27	MT
North China Pharmaceutical Company.Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	26/10/23	CI
North China Pharmaceutical Company.Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	18/08/23	CI
North China Pharmaceutical Company Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	26/04/23	CI
North China Pharmaceutical's Heart Drug Passes Regulatory Evaluation	13/02/23	MT
North China Pharmaceutical Company Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	26/10/22	CI
North China Pharmaceutical Company Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	28/04/22	CI
North China Pharmaceutical Company Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	28/04/22	CI
China Rolls Out New Rules to Fight Monopoly in API Drugmaking Market	19/11/21	MT
North China Pharmaceutical Company Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	22/10/21	CI
North China Pharmaceutical Company Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	24/08/21	CI
Chinese vitamin C price-fixing lawsuit thrown out by U.S. appeals court	10/08/21	RE
North China Pharmaceutical Company Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	28/04/21	CI
North China Pharmaceutical Company. Ltd completed the acquisition of North China Pharmaceutical Group Corporation Veterinary Co., Ltd., from North China Pharmaceutical Group Corp.	01/12/20	CI
Jizhong Energy Resources Co., Ltd. completed the acquisition of a 10% stake in North China Pharmaceutical Company. Ltd from Jizhong Energy Group Company Limited.	01/11/20	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights North China Pharmaceutical Company.Ltd

Equities

600812

CNE000000D16

Highlights

Filters